Boron analysis and boron imaging in biological materials for Boron Neutron Capture Therapy (BNCT)

Critical Reviews in Oncology/Hematology

Volumn 68, Issue 1, 2008, Pages 66-90

  Wittig, Andrea ^a   Michel, Jean ^b   Moss, Raymond L ^c   Stecher Rasmussen, Finn ^d   Arlinghaus, Heinrich F ^e   Bendel, Peter ^f   Mauri, Pier Luigi ^g   Altieri, Saverio ^h   Hilger, Ralf ^a   Salvadori, Piero A ⁱ   Menichetti, Luca ⁱ   Zamenhof, Robert ^j   Sauerwein, Wolfgang A G ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b UNIVERSITÉ DE REIMS CHAMPAGNE ARDENNE   (France)

^c TNO   (Netherlands)

^d NCT Physics   (Netherlands)

^e UNIVERSITY OF MÜNSTER   (Germany)

^f WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^g INSTITUTE OF BIOMEDICAL TECHNOLOGIES   (Italy)

^h UNIVERSITY OF PAVIA   (Italy)

ⁱ INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

^j INDIANA UNIVERSITY   (United States)

more..

Author keywords

Electron Energy Loss Spectroscopy; Inductively Coupled Plasma Mass Spectroscopy; Ion Trap Mass Spectrometry; laser SNMS; Neutron Capture Radiography; Nuclear Magnetic Resonance; Positron Emission Tomography; Prompt Gamma ray Spectroscopy

Indexed keywords

4 BORONOPHENYLALANINE; 4 BORONOPHENYLALANINE B 10; 4 BORONOPHENYLALANINE F 18; BORON; BORON 10; BORON 11; BORON DERIVATIVE; DIMER; FLUORODEOXYGLUCOSE F 18; RADIOPHARMACEUTICAL AGENT; SODIUM MERCAPTOUNDECAHYDRO CLOSO DODECABORATE B 10; UNCLASSIFIED DRUG;

ALPHA RADIATION; ALPHA SPECTROSCOPY; AUTORADIOGRAPHY; CANCER RADIOTHERAPY; COLORECTAL CARCINOMA; DOSIMETRY; DRUG TISSUE LEVEL; ELECTRON ENERGY LOSS SPECTROSCOPY; GAMMA RADIATION; GAMMA SPECTROMETRY; GLIOBLASTOMA; HEAD AND NECK CARCINOMA; HEAD AND NECK TUMOR; HIGH RESOLUTION ALPHA AUTORADIOGRAPHY; HUMAN; IMAGING; INDUCTIVELY COUPLED PLASMA SPECTROSCOPY; ION TRAP MASS SPECTROMETRY; LASER; LASER POST IONIZATION SECONDARY NEUTRAL MASS SPECTROMETRY; LIVER METASTASIS; LYMPH NODE METASTASIS; MELANOMA; MOUTH CANCER; NEUTRON CAPTURE RADIOGRAPHY; NEUTRON CAPTURE THERAPY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PROTEOMICS; RADIOFREQUENCY; RADIOGRAPHY; REVIEW; SPECTROSCOPY; SQUAMOUS CELL CARCINOMA; THYROID CARCINOMA; TREATMENT OUTCOME; TREATMENT PLANNING;

AUTORADIOGRAPHY; BORON; BORON NEUTRON CAPTURE THERAPY; HUMANS; ISOTOPES; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MASS SPECTROMETRY; NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY; RADIOBIOLOGY; SPECTROMETRY, GAMMA; SPECTROPHOTOMETRY, ATOMIC; SPECTROSCOPY, ELECTRON ENERGY-LOSS; TISSUE DISTRIBUTION;

EID: 50449087145     PISSN: 10408428     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.critrevonc.2008.03.004     Document Type: Review

References (129)

1. Pisarev M.A., Dagrosa M.A., and Juvenal G.J. Application of boron neutron capture therapy to the treatment of anaplastic thyroid carcinoma: current status and future perspectives. Curr Opin Endocrinol Diab 12 (2005) 352-355
2. van Rij C.M., Wilhelm A.J., Sauerwein W.A., and van Loenen A.C. Boron neutron capture therapy for glioblastoma multiforme. Pharm World Sci 27 (2005) 92-95
3. Busse P.M., Harling O.K., Palmer M.R., et al. A critical examination of the results from the Harvard-MIT NCT program phase I clinical trial of neutron capture therapy for intracranial disease. J Neurooncol 62 (2003) 111-121
4. Nakagawa Y., Pooh K., Kobayashi T., et al. Clinical review of the Japanese experience with boron neutron capture therapy and a proposed strategy using epithermal neutron beams. J Neurooncol 62 (2003) 87-99
5. Coderre J.A., Turcotte J.C., Riley K.J., Binns P.J., Harling O.K., and Kiger III W.S. Boron neutron capture therapy: cellular targeting of high linear energy transfer radiation. Technol Cancer Res Treat 2 (2003) 355-375
6. Sauerwein W., and Zurlo A. The EORTC boron neutron capture therapy (BNCT) group: achievements and future projects. Eur J Cancer 38 (2002) S31-S34
7. Thellier M., Dérue C., Tafforeau M., Verdus M.C., Massiot P., and Ripoll C. Physical methods for in vitro analytical imaging in the microscopic range in biology using radioactive or stable isotopes. J Trace Microprobe Tech 19 (2001) 143-162
8. Thellier M., Chevallier A., His I., et al. Methodological developments for application to the study of physiological boron and to boron neutron capture therapy. J Trace Microprobe Tech 19 (2001) 623-657
9. Sah R.N., and Brown H. Techniques for boron determination and their application to the analysis of plant and soil samples. Plant Soil 193 (1997) 121-148
10. Sauerwein W. Principles and history of neutron capture therapy. Strahlenther Onkol 169 (1993) 1-6
11. Trivillin V.A., Heber E.M., Nigg D.W., et al. Therapeutic success of boron neutron capture therapy (BNCT) mediated by a chemically non-selective boron agent in an experimental model of oral cancer: a new paradigm in BNCT radiobiology. Radiat Res 166 (2006) 387-396
12. Kamida A., Obayashi S., Kato I., et al. Effects of boron neutron capture therapy on human oral squamous cell carcinoma in a nude mouse model. Int J Radiat Biol 82 (2006) 21-29
13. Dagrosa M.A., Viaggi M., Rebagliati R.J., et al. Biodistribution of p-borophenylalanine (BPA) in dogs with spontaneous undifferentiated thyroid carcinoma (UTC). Appl Radiat Isot 61 (2004) 911-915
14. Miura M., Morris G.M., Micca P.L., et al. Synthesis of copper octabromotetracarboranylphenylporphyrin for boron neutron capture therapy and its toxicity and biodistribution in tumour-bearing mice. Br J Radiol 77 (2004) 573-580
15. Gonzalez S.J., Bonomi M.R., Santa Cruz G.A., et al. First BNCT treatment of a skin melanoma in Argentina: dosimetric analysis and clinical outcome. Appl Radiat Isot 61 (2004) 1101-1105
16. Zonta A., Prati U., Roveda L., et al. La terapia per cattura neutronica (BNCT) dei tumori epatici. Boll Soc Med Chir 114 (2000) 123-144
17. Zonta A., Pinelli T., Prati U., et al. La terapia per cattura neutronica (BNCT) dei tumori epatici diffusi: prima applicazione clinica. In: Alessiani M., Magrassi L., and Knerich R. (Eds). Atti della XX Riunione Clinico-scientifica del Dipartimento di Chirurgia-Recenti Acquisizioni nel trattamento del traumatizzato cranio-vertebrale ed abdominale-, Pavia (2003), Università degli Studi IRCCS Policlinico, S. Matteo 81-91
18. Wittig A., Malago M., Collette L., et al. Uptake of two (10)B-compounds in liver metastases of colorectal adenocarcinoma for extracorporeal irradiation with boron neutron capture therapy (EORTC trial 11001). Int J Cancer 122 (2008) 1164-1171
19. Suzuki M., Sakurai Y., Nagata K., et al. Impact of intra-arterial administration of boron compounds on dose-volume histograms in boron neutron capture therapy for recurrent head-and-neck tumors. Int J Radiat Oncol Biol Phys 66 (2006) 1523-1527
20. Kankaanranta L., Seppälä T., Koivunoro H., et al. Boron neutron capture therapy in the treatment of locally recurred head and neck cancer. Int J Radiat Oncol Biol Phys 69 (2007) 475-482
21. Soloway A.H., Hatanaka H., and Davis M.A. Penetration of brain and brain tumor. VII. Tumor binding sulfhydryl boron compounds. J Med Chem 10 (1967) 714-717
22. Kageji T., Nagahiro S., Mizobuchi Y., Toi H., Nakagawa Y., and Kumada H. Boron neutron capture therapy using mixed epithermal and thermal neutron beams in patients with malignant glioma-correlation between radiation dose and radiation injury and clinical outcome. Int J Radiat Oncol Biol Phys 65 (2006) 1446-1455
23. Hatanaka H. A revised boron-neutron capture therapy for malignant brain tumors. Interim clinical result with the patients excluding previous treatments. J Neurol 209 (1975) 81-94
24. Wittig A., Moss R.L., Stecher-Rasmussen F., et al. Neutron activation of patients following boron neutron capture therapy of brain tumors at the high flux reactor (HFR) Petten (EORTC trials 11961 and 11011). Strahlenther Onkol 181 (2005) 774-782
25. Sauerwein W., Moss R., Rassow J., et al. Organisation and management of the first clinical trial of BNCT in Europe (EORTC protocol 11961). Strahlenther Onkol 175 (1999) 108-111
26. Snyder H.R., Reedy A.J., and Lennarj W.J. Synthesis of aromatic boronic acids. Aldehyde boronic acids and a boronic acid analog of tyrosine. J Am Chem Soc 80 (1958) 835-838
27. Kiger W.S., Palmer M.R., Riley K.J., Zamenhof R.G., and Busse P.M. A pharmacokinetic model for the concentration of 10B in blood after boronophenylalanine-fructose administration in humans. Radiat Res 155 (2001) 611-618
28. Bergenheim A.T., Capala J., Roslin M., and Henriksson R. Distribution of BPA and metabolic assessment in glioblastoma patients during BNCT treatment: a microdialysis study. J Neurooncol 71 (2005) 287-293
29. Kato I., Ono K., Sakurai Y., et al. Effectiveness of BNCT for recurrent head and neck malignancies. Appl Radiat Isot 61 (2004) 1069-1073
30. Aihara T., Hiratsuka J., Morita N., et al. First clinical case of boron neutron capture therapy for head and neck malignancies using 18f-BPA PET. Head Neck 28 (2006) 850-855
31. Kobayashi T., and Kanda K. Microanalysis system of ppm order B-10 concentrations in tissue for neutron capture therapy by prompt gamma-ray spectrometry. Nucl Instrum Methods Phys Res 204 (1983) 525-531
32. Konijnenberg M.W., Raaijmakers C.P.J., Constantine G., et al. Prompt gamma-ray analysis to determine 10B-concentrations. In: Soloway A.H. (Ed). Advances in neutron capture therapy (1993), Plenum Press, New York 419-422
33. Raaijmakers C.P.J., Konijnenberg M.W., Dewit L., et al. Monitoring of blood-10B concentration for boron neutron capture therapy using prompt gamma-ray analysis. Acta Oncol 34 (1995) 517-523
34. Fairchild R.G., Gabel D., Laster B.H., Greenberg D., Kiszenick W., and Micca P.L. Microanalytical techniques for boron analysis using the 10B(n, alpha)7li reaction. Med Phys 13 (1986) 50-56
35. Matsumoto T., Aoki M., and Aizawa O. Phantom experiment and calculation for in vivo 10boron analysis by prompt gamma ray spectroscopy. Phys Med Biol 36 (1991) 329-338
36. Mukai K., Nakagawa Y., and Matsumoto K. Prompt gamma ray spectrometry for in vivo measurement of boron-10 concentration in rabbit brain tissue. Neurol Med Chir (Tokyo) 35 (1995) 855-860
37. Stecher-Rasmussen F., Abrahams K., and Kopecky J. Circular polarization of neutron capture gamma-rays from Al, Ar and Ca. Nucl Phys (1972) A181-A225
38. Munck af Rosenschold P.M., Verbakel W.F., Ceberg C.P., Stecher-Rasmussen F., and Persson B.R. Towards clinical application of prompt gamma spectroscopy for in vivo monitoring of boron uptake in boron neutron capture therapy. Med Phys 28 (2001) 787-795
39. Verbakel W.F., Sauerwein W., Hideghety K., and Stecher-Rasmussen F. Boron concentrations in brain during boron neutron capture therapy: in vivo measurements from the phase I trial EORTC 11961 using a gamma-ray telescope. Int J Radiat Oncol Biol Phys 55 (2003) 743-756
40. Ishikawa M., Kobayashi T., Sakurai Y., and Kanda K. Optimizing technique for a prompt gamma-ray spect collimator system. J Radiat Res 42 (2001) 387-400
41. Ward N.I., Abou-Shakra F.R., and Durrant S.F. Trace elemental content of biological materials-a comparison of NAA and ICP-MS analysis. Biol Trace Elm Res 26/27 (1990) 177-187
42. Vanhoe H., Dams R., Vandecasteele C., and Versieck J. Trace element reference values in serum determined by inductively coupled plasma atomic emission spectrometry. Anal Chim Acta 281 (1993) 401
43. Evans E., and Krahenbuhl U. Improved boron determination in biological material by inductively coupled plasma mass spectrometry. J Anal At Spectrom 9 (1994) 1249-1253
44. Probst T.U., Berryman N.G., Lemmen P., et al. Comparison of inductively coupled plasma atomic emission spectrometry and inductively coupled plasma mass spectrometry with quantitative neutron capture radiography for the determination of boron in biological samples from cancer therapy. J Anal At Spectrom 12 (1997) 1115-1122
45. Sun D.H., Ma R.L., McLeod C.W., Wang X.R., and Cox A.G. Determination of boron in serum, plasma and urine by inductively coupled plasma mass spectrometry (ICP-MS). Use of mannitol-ammonia as diluent and for eliminating memory effect. J Anal At Spectrom 15 (2000) 257-261
46. Al-Ammar A., Gupta R.K., and Barnes R.M. Elimination of boron memory effect in inductively coupled plasma-mass spectrometry by addition of ammonia. Spectrochim Acta-Part B 54 (1999) 1077-1084
47. Smith F., Wiederin D.R., Houk R.S., Egan C.B., and Serfass R.E. Measurement of boron concentration and isotope ratios in biological samples by inductivey coupled plasma mass spectrometry with direct injection nebulisation. Anal Chim Acta 248 (1991) 229-234
48. Evans E.H., and Giglio J.J. Interferences in inductively coupled plasma mass spectrometry-a review. J Anal At Spectrom 8 (1993) 1-18
49. Gregoire D.C. Determination of boron isotope ratios in geological materials by inductively coupled plasma mass spectrometry. Anal Chem 59 (1987) 2479-2484
50. Gregoire D.C. Determination of boron in fresh and saline waters by inductively coupled plasma mass spectrometry. J Anal At Spectrom 5 (1990) 623-626
51. Al-Ammar A., Reitznerová E., and Barnes R.M. Improving boron isotope ratio measurement precision with quadrupole inductively coupled plasma-mass spectrometry. Spectrochim Acta-Part B 55 (2000) 1861-1867
52. Evans S., and Krahenbuhl U. Boron analysis in biological material: microwave digestion procedure and determination by different methods. Fresenius Z Anal Chem 349 (1994) 454-459
53. Brown P.H., and Hu H. Phloem mobility of boron is species dependent: evidence for phloem mobility in sorbitol-rich species. Ann Bot 77 (1996) 497-505
54. Smith F.G., Wiederin D.R., Houk R.S., Egan C.B., and Serfass R.E. Measurement of boron concentration and isotope ratios in biological samples by inductively coupled plasma mass spectrometry with direct injection nebulisation. Anal Chim Acta 248 (1991) 229-234
55. Evans S.K., and Krahenbuhl U. Improved boron determination in biological material by inductively coupled plasma mass spectrometry. J Anal At Spectrom 9 (1994) 1249-1253
56. Vanhoe H., Dams R., Vandecasteele C., and Versieck J. Determination of boron in human serum by inductively coupled plasma mass spectrometry after a simple dilution of the sample. Anal Chim Acta 281 (1993) 401-411
57. Laakso J., Kulvik M., Ruokonen I., et al. Atomic emission method for total boron in blood during neutron-capture therapy. Clin Chem 47 (2001) 1796-1803
58. Ficq A. Autoradiographie par neutrons: Dosage du lithium dans les embryons d'amphibiens. C R Acad Sci 233 (1951) 1684-1685
59. Edwards L.C. Autoradiography by neutron activation: the cellular distribution of 10B in the transplanted mouse brain tumor. Int J Appl Radiat Isot 1 (1956) 184-190
60. Solares G.R., and Zamenhof R.G. A novel approach to the microdosimetry of neutron capture therapy. Part I. High-resolution quantitative autoradiography applied to microdosimetry in neutron capture therapy. Radiat Res 144 (1995) 50-58
61. Solares G.R., and Zamenhof R.G. A new approach to the microdosimetry of neutron capture therapy. Trans Am Nucl Soc 65 (1992) 153-157
62. Solares G.R., Zamenhof R.G., and Cano G. Microdosimetry and compound factors for neutron capture therapy. In: Barth R., and Soloway A. (Eds). Advances in neutron capture therapy (1993), Plenum Press, New York
63. Yam C.S., Solares G.R., and Zamenhof R.G. Validation of the HR microdosimetry. Trans Am Nucl Soc 71 (1994) 142-144
64. Yam C.S., Zamenhof R.G., and Solares G.R. Microdosimetric evaluation of boron compound efficacy. Trans Am Nucl Soc 73 (1995) 26-29
65. Kiger III W.S., Micca P.L., Morris G.M., and Coderre J.A. Boron microquantification in oral muscosa and skin following administration of a neutron capture therapy agent. Radiat Prot Dosimetry 99 (2002) 409-412
66. Alfassi Z.B., and Probst T.U. On the calibration curve for determination of boron in tissue by quantitative neutron capture radiography. NIM A 428 (1999) 502-507
67. Pugliesi R., and Pereira M.A.S. Study of the neutron radiography characteristics for the solid state nuclear track detector makrofol-de. NIM A 484 (2002) 613-618
68. Roveda L., Prati U., Bakeine J., et al. How to study boron biodistribution in liver metastases from colorectal cancer. J Chemother 16 Suppl. 5 (2004) 15-18
69. Altieri S., Bortolussi S., Bruschi P., et al. Boron absorption imaging in rat lung colon adenocarcinoma metastases. J Phys: Conf Ser 41 (2006) 123-126
70. Nano R., Barni S., Chiari P., et al. Efficacy of boron neutron capture therapy on liver metastases of colon adenocarcinoma: optical and ultrastructural study in the rat. Oncol Rep 11 (2004) 149-153
71. Chiaraviglio D., De Grazia F., Zonta A., et al. Evaluation of selective boron absorption in liver tumors. Strahlenther Oncol 165 (1989) 170-172
72. Enge W., Grabisch K., Beaujean R., and Bartholoma K.P. Etching behaviour of cellulose nitrate plastic detector under various etching conditions. NIM A 115 (1974) 263-270
73. Ziegler J.F., Biersack J.P., and Littmark U. The stopping and range of ions in solids, vol. 1 (1985), Pergamon Press, New York
74. Bennett B.D., Zha X., Gay I., and Morrison G.H. Intracellular boron localization and uptake in cell cultures using imaging secondary ion mass spectrometry (ion microscopy) for neutron capture therapy for cancer. Biol Cell 74 (1992) 105-108
75. Chandra S., and Morrison G.H. Sample preparation of animal tissue and cell cultures for secondary ion mass spectrometry (SIMS) microscopy. Biol Cell 74 (1992) 31-42
76. Chandra S., Smith D.R., and Morrison G.H. Subcellular imaging by dynamic SIMS ion microscopy. Anal Chem 72 (2000) 104A-114A
77. Chandra S., Lorey D.R.I., and Smith D.R. Quantitative subcellular secondary ion mass spectrometry (SIMS) imaging of boron-10 and boron-11 isotopes in the same cell delivered by two combined BNCT drugs: In vitro studies on human glioblastoma T98G cells. Radiat Res 157 (2002) 700-710
78. Smith D.R., Chandra S., Barth R.F., Yang W., Joel D.D., and Coderre J.A. Quantitative imaging and microlocalization of boron-10 in brain tumors and infiltrating tumor cells by SIMS ion microscopy: relevance to neutron capture therapy. Cancer Res 61 (2001) 8179-8187
79. Yokoyama K., Miyatake S.-I., Kajimoto Y., et al. Analysis of boron distribution in vivo for boron neutron capture therapy using two different boron compounds by secondary ion mass spectrometry. Radiat Res 167 (2007) 102-109
80. Arlinghaus H.F. Static secondary ion mass spectrometry (SSIMS) (2002), Wiley-VCH, Weinheim
81. Arlinghaus H.F. Laser-SNMS (2002), Wiley-VCH, Weinheim
82. Arlinghaus H.F., Spaar M.T., Switzer R.C., and Kabalka G.W. Imaging of boron in tissue at cellular level for boron neutron capture therapy. Anal Chem 69 (1997) 3169-3176
83. Fartmann M., Kriegeskotte C., Dambach S., Wittig A., Sauerwein W., and Arlinghaus H.F. Quantitative imaging of atomic and molecular species in cancer cultures with ToF-SIMS and laser-SNMS. Appl Surf Sci 231-232 (2004) 428-431
84. Arlinghaus H.F., Kriegeskotte C., Fartmann M., Wittig A., Sauerwein W., and Lipinsky D. Mass spectrometric characterization of elements and molecules in cell cultures and tissues. Appl Surf Sci 252 (2006) 6941-6948
85. Fartmann M., Dambach S., Kriegeskotte C., et al. Subcellular imaging of freeze-fractured cell cultures by ToF-SIMS and laser-SNMS. Appl Surf Sci 203-204 (2003) 726-729
86. Wittig A., Wiemann M., Fartmann M., et al. Preparation of cells cultured on silicon wafers for mass spectrometry analysis. Microsc Res Tech 66 (2005) 248-258
87. Arlinghaus H.F., Fartmann M., Kriegeskotte C., et al. Subcellular imaging of cell cultures and tissue for boron localization with laser-SNMS. Surf Interf Anal 36 (2004) 698-701
88. Bourdos N., Kollmer F., Benninghoven A., Sieber M., and Galla H.J. Imaging of domain structures in a one-component lipid monolayer by time-of-flight secondary ion mass spectrometry. Langmuir 16 (2000) 1481-1484
89. Neumann M., Kunz U., Lehmann H., and Gabel D. Determination of the subcellular distribution of mercaptoundecahydro-closo-dodecaborate (BSH) in human glioblastoma multiforme by electron microscopy. J Neurooncol 57 (2002) 97-104
90. Zhu Y., Egerton R.F., and Malac M. Concentration limits for the measurement of boron by electron energy loss spectroscopy and electron-spectroscopic imaging. Ultramicroscopy 87 (2001) 135-145
91. Michel J., Sauerwein W., Wittig A., Balossier G., and Zierold K. Subcellular localization of boron in cultured melanoma cells by electron energy-loss spectroscopy of freeze-dried cryosections. J Microsc 210 (2003) 25-34
92. Isaacson I., and Johnson D. The microanalysis of light elements using transmitted energy-loss electrons. Ultramicroscopy 1 (1975) 33-52
93. Leapman R.D., Kocsis E., Zhang G., Talbot T.L., and Laquerriere P. Three dimensional distribution of elements in biological samples by energy filtered electron tomography. Ultramicroscopy 100 (2004) 115-125
94. Michel J., and Bonnet N. Optimization of digital filters for the detection of trace elements in electron energy loss spectroscopy. Gaussian, homomorphic and adaptive filters. Ultramicroscopy 88 (2001) 231-242
95. Michel J., Balossier G., Wittig A., Sauerwein W., and Zierold K. EELS spectrum-imaging for boron detection in biological cryofixed tissues. Instrum Sci Technol 33 (2005) 631-644
96. March R.E. An introduction to quadrupole ion trap mass spectrometry. J Mass Spectrom 32 (1997) 351-369
97. Mauri P.L., Minoggio M., Lemoli L., et al. Liquid chromatography/atmospheric pressure chemical ionization ion trap mass spectrometry of terpene lactones in plasma of animals. J Pharm Biom Anal 32 (2003) 633-639
98. Mauri P.L., Basilico F., Pietta P.G., Pasini E., Monti D., and Sauerwein W. New approach for the detection of BSH and its metabolites using capillary electrophoresis and electrospray ionization mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 788 (2003) 9-16
99. Basilico F., Sauerwein W., Pozzi F., Wittig A., Moss R., and Mauri P.L. Analysis of 10B antitumoral compounds by means of flow-injection into ESI-MS/MS. J Mass Spectrom 40 (2005) 1546-1549
100. Washburn M.P., Wolters D., and Yates III J.R. Large-scale analysis of the yeast proteome by multidimensional protein identification technology. Nat Biotechnol 19 (2001) 242-247
101. Mauri P., Scarpa A., Nascimbeni A.C., et al. Identification of proteins released by pancreatic cancer cells by multidimensional protein identification technology: a strategy for identification of novel cancer markers. FASEB J 19 (2005) 1125-1127
102. Beretta L. Proteomics from the clinical perspective: many hopes and much debate. Nat Methods 4 (2007) 787-796
103. Callaghan P.T. Principles of nuclear magnetic resonance microscopy (1993), Claredon, Oxford
104. Bendel P., Koudinova N., and Salomon Y. In vivo imaging of the neutron capture therapy agent BSH in mice using 10B MRI. Magn Reson Med 46 (2001) 13-17
105. Bendel P., Koudinova N., Salomon Y., Hideghéty K., and Sauerwein W. Imaging of BSH by 10B MRI. In: Sauerwein W., Moss R., and Wittig A. (Eds). Research and development in neutron capture therapy (2002), Monduzzi Editore, Bologna 877-880
106. Bendel P. Biomedical applications of 10B and 11B NMR. NMR Biomed 18 (2005) 74-82
107. Martínez M.J., Ziegler S.I., and Beyer T. PET and PET/CT: basic principles and instrumentation. Recent Results Cancer Res 170 (2008) 1-23
108. Watabe H., Ikoma Y., Kimura Y., Naganawa M., and Shidahara M. PET kinetic analysis-compartmental model. Ann Nucl Med 20 (2006) 583-588
109. Schöder H., Erdi Y.E., Larson S.M., and Yeung H.W. PET/CT: a new imaging technology in nuclear medicine. Eur J Nucl Med Mol Imaging 30 (2003) 1419-1437
110. Lecchi M., Fossati P., Elisei F., Orecchia R., and Lucignani G. Current concepts on imaging in radiotherapy. Eur J Nucl Med Mol Imaging 35 (2008) 821-837
111. Grosu A.L., Piert M., Weber W.A., et al. Positron emission tomography for radiation treatment planning. Strahlenther Onkol 181 (2005) 483-499
112. Jacobs A.H., Kracht L.W., Gossmann A., et al. Imaging in Neurooncology. NeuroRx 2 (2005) 333-347
113. Cerullo N., Daquino G.G., Muzi L., and Esposito J. Development of a treatment planning system for BNCT based on positron emission tomography data: Preliminary results. Nucl Inst Meth Phys Res Sect B: Beam Interact Mater Atoms 213 (2004) 637-640
114. Imahori Y., Ueda S., Ohmori Y., et al. Positron emission tomography-based boron neutron capture therapy using boronophenylalanine for high-grade gliomas: Part II. Clin Cancer Res 4 (1998) 1833-1841
115. Kabalka G.W., Smith G.T., Dyke J.P., et al. Evaluation of fluorine-18-BPA-fructose for boron neutron capture treatment planning. J Nucl Med 38 (1997) 1762-1767
116. Imahori Y., Ueda S., Ohmori Y., et al. Fluorine-18-labeled fluoroboronophenylalanine PET in patients with glioma. J Nucl Med 39 (1998) 325-333
117. Ariyoshi Y., Miyatake S., Kimura Y., et al. Boron neuron capture therapy using epithermal neutrons for recurrent cancer in the oral cavity and cervical lymph node metastasis. Oncol Rep 18 (2007) 861-866
118. Havu-Aurén K., Kiiski J., Lehtiö K., et al. Uptake of 4-borono-2-[18f]fluoro-l-phenylalanine in sporadic and neurofibromatosis 2-related schwannoma and meningioma studied with PET. Eur J Nucl Med Mol Imaging 34 (2007) 87-94
119. Kabalka G.W., Nichols T.L., Smith G.T., Miller L.F., Khan M.K., and Busse P.M. The use of positron emission tomography to develop boron neutron capture therapy treatment plans for metastatic malignant melanoma. J Neurooncol 62 (2003) 187-195
120. Takahashi Y., Imahori Y., and Mineura K. Prognostic and therapeutic indicator of fluoroboronophenylalanine positron emission tomography in patients with gliomas. Clin Cancer Res 9 (2003) 5888-5895
121. Wyss M.T., Hofer S., Hefti M., et al. Spatial heterogeneity of low-grade gliomas at the capillary level: A PET study on tumor blood flow and amino acid uptake. J Nucl Med 48 (2007) 1047-1052
122. Wang H.E., Wu S.Y., Chang C.W., et al. Evaluation of f-18-labeled amino acid derivatives and [18f]FDG as PET probes in a brain tumor-bearing animal model. Nucl Med Biol 32 (2005) 367-375
123. Ishiwata K., Kawamura K., Wang W.F., et al. Evaluation of o-[11c]methyl-l-tyrosine and o-[18f]fluoromethyl-l-tyrosine as tumor imaging tracers by PET. Nucl Med Biol 31 (2004) 191-198
124. Zierold K., Michel J., and Sauerwein W. Subcellular localization of boron compounds by electron energy loss spectroscopy of cryosections. Eur J Cell Biol/Optik 78/110 (1999) 79
125. Kriegeskotte C., Möller J., Lipinsky D., et al. Imaging of atomic and molecular species in tissue with laser-SNMS for pharmaceutical studies. Surf Interface Anal 38 (2006) 121-125
126. Coderre J.A., Chanana A.D., Joel D.D., et al. Biodistribution of boronophenylalanine in patients with glioblastoma multiforme: boron concentration correlates with tumor cellularity. Radiat Res 149 (1998) 163-170
127. Sauerwein W., Altieri S., Mauri P., et al. Boron concentration in tissues-an urgent need for standards. In: Nakagawa Y. (Ed). 12th International Congress on Neutron Capture Therapy (2007) 53
128. Thellier M., Hennequin E., Heurteaux C., et al. Quantitative estimations in neutron capture radiography. Nucl Inst Meth Phys Res B 30 (1988) 567-579
129. Haselsberger K., Radner H., Gössler W., Schagenhaufen C., and Pendl G. Subcellular boron-10 localization in glioblastoma for boron neutron capture therapy with Na2B12H11SH. J Neurosurg 81 (1994) 741-744